HOMA-IR as a Predictor of PAI-1 Levels in Women with Severe Obesity

Fabiana Martins Kattah,Milijana Janjusevic,Nayra Figueiredo,Emilly Santos Oliveira,Glaucia Carielo Lima,Ana Raimunda Dâmaso,Lila Missae Oyama,Alessandra Lucia Fluca,Paulo Reis Eselin de Melo,Maria Aderuza Horst,Aneta Aleksova,Flávia Campos Corgosinho
DOI: https://doi.org/10.3390/biomedicines12061222
IF: 4.757
2024-05-31
Biomedicines
Abstract:Background: Obesity is a chronic inflammatory disorder that increases the risk of cardiovascular diseases (CVDs). Given the high CVD mortality rate among individuals with obesity, early screening should be considered. Plasminogen activator inhibitor (PAI-1), a cytokine that links obesity and CVDs, represents a promising biomarker. However, PAI-1 is not part of the clinical routine due to its high cost. Therefore, it is necessary to find good predictors that would allow an indirect assessment of PAI-1. Methods: This study enrolled 47 women with severe obesity (SO). The obtained anthropometric measurements included weight, height, neck (NC), waist (WC), and hip circumference (HC). Blood samples were collected to analyse glucose and lipid profiles, C-reactive protein, liver markers, adiponectin, and PAI-1 (determined by ELISA immunoassay). Homeostasis model assessment-adiponectin (HOMA-AD), homeostasis model assessment of insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), triglyceride–glucose index (TyG), and atherogenic index of plasma (AIP) were calculated. The women were grouped according to PAI-1 levels. The data were analysed using IBM SPSS Statistics, version 21. The significance level for the analysis was set at 5%. Results: Women with SO who have higher levels of PAI-1 have lower values of high-density lipoprotein cholesterol (HDL) (p = 0.037) and QUICKI (0.020) and higher values of HOMA-AD (0.046) and HOMA-IR (0.037). HOMA-IR was demonstrated to be a good predictor of PAI-1 in this sample (B = 0.2791; p = 0.017). Conclusions: HOMA-IR could be used as a predictor of PAI-1 levels, pointing out the relevance of assessing glycaemic parameters for the prevention of CVDs in women with SO.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to explore whether HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) can serve as a predictor of PAI-1 (Plasminogen Activator Inhibitor-1) levels in severely obese women. Specifically, the researchers hope to verify whether certain indices (such as HOMA-IR, HOMA-AD, QUICKI, etc.) can predict PAI-1 levels to better screen patients at higher cardiovascular risk. ### Background Obesity is a chronic inflammatory disease that increases the risk of cardiovascular diseases (CVD). PAI-1 is a cytokine associated with obesity and cardiovascular diseases and is considered a potential biomarker. However, due to the high cost of PAI-1 testing, its application in routine clinical examinations is limited. Therefore, finding good predictive indicators that can indirectly assess PAI-1 levels is particularly important. ### Research Methods The study included 47 severely obese women (BMI > 40 kg/m²). Researchers collected anthropometric data such as weight, height, neck circumference, waist circumference, and hip circumference, and took blood samples to analyze blood glucose and lipid profiles, C-reactive protein, liver function indicators, adiponectin, and PAI-1 (measured by ELISA immunoassay). Additionally, HOMA-AD, HOMA-IR, QUICKI, TyG index, and AIP were calculated. Subjects were grouped according to PAI-1 levels, and data analysis was performed using IBM SPSS Statistics 21, with a significance level set at 5%. ### Main Results - **Women with higher PAI-1 levels**: These women had lower high-density lipoprotein cholesterol (HDL) and QUICKI values, while HOMA-AD and HOMA-IR values were higher. - **HOMA-IR as a predictor of PAI-1**: HOMA-IR was proven to be a good predictor of PAI-1 (B = 0.2791; p = 0.017). ### Conclusion HOMA-IR can be used as a predictor of PAI-1 levels, emphasizing the importance of assessing glucose metabolism parameters in preventing cardiovascular diseases in severely obese women. ### Keywords PAI-1; cardiovascular diseases; inflammation; severe obesity; HOMA-IR Through this study, the authors hope to provide clinicians with a more cost-effective method to assess cardiovascular risk in severely obese women.